08048035968
Mounjaro 15 mg Injection affordable injection to USA - Los Angeles | Phoenix Exim | Trusted Exporter

1. General Information

Mounjaro 15 mg Prefilled Pen Injection contains tirzepatide, a prescription medicine belonging to the dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist class.

It is used along with diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus. Mounjaro is administered as a once-weekly subcutaneous injection. The 15 mg strength is the maximum recommended adult dose under current U.S. prescribing information.

Phoenix Exim is a pharmaceutical exporter from Nagpur, India, supplying pharmaceutical products for international markets including the USA, UK, Australia, Singapore, Canada, South Korea and UAE, subject to applicable prescription, import and regulatory requirements.


2. Product Information

Product DetailInformation
Brand NameMounjaro
Active IngredientTirzepatide
Strength15 mg/0.5 mL
Dosage FormPrefilled single-dose injection pen
Drug ClassGIP and GLP-1 receptor agonist
RouteSubcutaneous injection
FrequencyOnce weekly
Prescription StatusPrescription medicine
Manufacturer/BrandEli Lilly
Primary U.S. IndicationType 2 diabetes mellitus

Mounjaro is available in several strengths, including 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg per 0.5 mL.


3. Uses of Mounjaro 15 mg

Mounjaro is prescribed as an adjunct to diet and exercise to improve glycemic control in people with type 2 diabetes mellitus.

Its effects may include:

  • Helping lower blood glucose levels
  • Improving glycemic control
  • Supporting improved insulin response after meals
  • Reducing appetite in some patients
  • Helping patients achieve better blood-sugar management when used as prescribed

Mounjaro should be used under the supervision of a qualified healthcare professional.


4. Benefits of Mounjaro 15 mg

Potential therapeutic benefits include:

  • Effective glucose management: Helps improve blood glucose control in type 2 diabetes.
  • Dual-action mechanism: Tirzepatide activates both GIP and GLP-1 receptors.
  • Once-weekly administration: The treatment is designed for convenient weekly dosing.
  • Dose flexibility: Patients can be gradually increased through different strengths according to their healthcare provider's recommendation.
  • Appetite effects: Tirzepatide can reduce appetite and food intake in some patients.
  • Weight reduction observed in studies: Weight loss has occurred in clinical studies, although Mounjaro's U.S. indication is for glycemic control in type 2 diabetes rather than being labeled as a weight-loss medicine.

Individual results vary and treatment should be personalized by a healthcare professional.


5. Side Effects of Mounjaro 15 mg

Like all prescription medicines, Mounjaro may cause side effects.

The most frequently reported adverse reactions include:

  • Nausea
  • Diarrhea
  • Decreased appetite
  • Vomiting
  • Constipation
  • Indigestion/dyspepsia
  • Abdominal pain

Some potentially serious adverse effects can occur, including pancreatitis, gallbladder problems, serious allergic reactions, kidney problems associated with dehydration, and severe gastrointestinal reactions.

Seek medical attention promptly if severe or unusual symptoms occur.


6. Common Side Effects

Common side effects may include:

  1. Nausea
  2. Diarrhea
  3. Reduced appetite
  4. Vomiting
  5. Constipation
  6. Abdominal discomfort or pain
  7. Indigestion

Gastrointestinal effects can be particularly noticeable when treatment is initiated or the dose is increased. Following the prescribed dose-escalation schedule can help reduce gastrointestinal adverse reactions.


7. How to Use Mounjaro 15 mg

Mounjaro is administered once weekly by subcutaneous injection.

The U.S. prescribing information recommends:

  • Starting treatment at 2.5 mg once weekly.
  • After 4 weeks, increasing to 5 mg once weekly.
  • If additional glycemic control is required, increasing in 2.5 mg increments after at least 4 weeks at the current dose.
  • The maximum adult dose is 15 mg once weekly.
  • Injection sites include the abdomen, thigh or upper arm.
  • Injection sites should be rotated.
  • Mounjaro should not be injected into a vein or muscle.

Important: A 15 mg pen is a high maintenance dose and should not be used as an initial dose unless specifically prescribed by a healthcare professional.

For a missed dose, the manufacturer's instructions state that it can be taken within 4 days (96 hours); if more than 4 days have passed, the missed dose should be skipped and the next dose taken on the regular day. Two doses should not be taken within 3 days of each other.


8. How Mounjaro Works

Mounjaro contains tirzepatide, which activates two hormone receptors:

GIP receptor + GLP-1 receptor

This dual action helps regulate blood glucose by enhancing glucose-dependent insulin secretion and reducing glucagon secretion. Tirzepatide also slows gastric emptying and can affect appetite and food intake.

In simple terms, Mounjaro helps the body respond more effectively to glucose-related hormonal signals, supporting better blood-sugar control when combined with appropriate diet and exercise.


9. Safety Advice

Mounjaro should only be used according to a healthcare professional's prescription.

Important warnings

Mounjaro carries a boxed warning concerning thyroid C-cell tumors observed in rats. It is unknown whether this risk applies to humans. It is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Patients should also inform their healthcare provider about:

  • Previous pancreatitis
  • Gallbladder problems
  • Severe gastrointestinal problems
  • Diabetic retinopathy
  • Kidney problems
  • Allergies to tirzepatide or its ingredients
  • Other diabetes medicines, particularly insulin or insulin secretagogues
  • Planned surgery or procedures involving anesthesia or deep sedation
  • Pregnancy or plans to become pregnant

Mounjaro may increase the risk of hypoglycemia when used with insulin or certain insulin secretagogues.

Storage

Mounjaro pens should generally be stored in a refrigerator at 2°C–8°C (36°F–46°F), kept in the original carton to protect from light, and should not be frozen. Always follow the storage instructions supplied with the specific product.


10. Frequently Asked Questions (FAQs)

Q1. What is Mounjaro 15 mg used for?

Mounjaro 15 mg is used with diet and exercise to improve blood glucose control in adults with type 2 diabetes.

Q2. What is the active ingredient in Mounjaro?

The active ingredient is tirzepatide.

Q3. How often is Mounjaro 15 mg taken?

It is administered once weekly, as prescribed by a healthcare professional.

Q4. Is 15 mg the starting dose?

No. The recommended adult starting dose is 2.5 mg once weekly, followed by gradual dose escalation. 15 mg is the maximum adult dose in the U.S. prescribing information.

Q5. Where is Mounjaro injected?

It is injected subcutaneously into the abdomen, thigh or upper arm, with injection sites rotated.

Q6. Can Mounjaro be used for weight loss?

Tirzepatide can produce weight loss, but Mounjaro's U.S. indication is type 2 diabetes. It should not be promoted or used as a weight-loss treatment outside its approved indication and a healthcare professional's advice.

Q7. What are the common side effects?

Nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion and abdominal pain are among the commonly reported adverse reactions.

Q8. Can Mounjaro be used during pregnancy?

Pregnancy requires medical evaluation because available evidence raises concern about potential fetal harm. Patients who are pregnant or planning pregnancy should discuss Mounjaro with their healthcare provider.

Q9. Does Mounjaro require refrigeration?

Yes. Mounjaro pens are generally refrigerated at 2°C–8°C and should not be frozen. Follow the product-specific storage instructions.

Q10. Is Mounjaro a prescription medicine?

Yes. Mounjaro is a prescription medicine and should be obtained and used in accordance with applicable medical and pharmaceutical regulations.


11. Substitute for Mounjaro 15 mg

There is no universal substitute that is appropriate for every patient. A healthcare professional should select an alternative based on the patient's diagnosis, glucose levels, medical history, other medicines and treatment goals.

Depending on the clinical situation, physicians may consider other diabetes medicines or incretin-based therapies, such as:

  • Other GLP-1 receptor agonist medicines
  • Other diabetes medications
  • Insulin therapy where clinically appropriate

Do not switch from Mounjaro 15 mg to another medicine or another tirzepatide product without medical advice.


12. SEO Keywords

  • Mounjaro 15 mg Prefilled Pen Injection
  • Mounjaro 15 mg Injection exporter
  • Tirzepatide 15 mg injection
  • Tirzepatide 15 mg prefilled pen
  • Mounjaro 15 mg pharmaceutical exporter
  • Mounjaro 15 mg supplier India
  • Mounjaro 15 mg exporter from India
  • Mounjaro 15 mg exporter Nagpur
  • Tirzepatide injection exporter India
  • Mounjaro 15 mg international supplier
  • Mounjaro 15 mg diabetes injection
  • Tirzepatide diabetes treatment
  • Mounjaro prescription injection supplier
  • Mounjaro 15 mg pharmaceutical supply
  • Mounjaro 15 mg B2B supplier
  • Mounjaro 15 mg medicine exporter
  • Tirzepatide pharmaceutical supplier
  • Mounjaro 15 mg bulk pharmaceutical supply
  • Mounjaro 15 mg export from Nagpur
  • Tirzepatide injection supplier India
  • Mounjaro 15 mg USA pharmaceutical supply
  • Mounjaro 15 mg UK pharmaceutical supply
  • Mounjaro 15 mg Australia pharmaceutical supply
  • Mounjaro 15 mg Canada pharmaceutical supply
  • Mounjaro 15 mg Singapore pharmaceutical supply
  • Mounjaro 15 mg South Korea pharmaceutical supply
  • Mounjaro 15 mg UAE pharmaceutical supply
  • Trusted pharma exporter Nagpur India
  • Verified pharmaceutical exporter India
  • Tirzepatide medicine exporter India
  • Mounjaro 15 mg international pharmaceutical distributor
  • Mounjaro 15 mg prescription medicine supplier
  • Tirzepatide 15 mg injection supplier
  • Mounjaro prefilled pen pharmaceutical exporter
  • Phoenix Exim pharmaceutical exporter
Aug 11th, 2026 2:56 PM

Keywords